Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
2.
Rio de Janeiro; s.n; 1991. ix,74 p. ilus.
Thesis in Portuguese | LILACS, ColecionaSUS, Inca | ID: biblio-927692

ABSTRACT

Grupos de camundongos B10A portadores de fibrossarcoma B10MC2 foram tratados com agentes que estimulam a resposta de eosinófilos, tais como Ciclofosfamida (cy) e antígenos de Schistosonma mansoni (SMA) ou ambos. O crescimento de tumores foi bastante atenuado no grupo de camundongos que recebeu 4 casais de verme adulto de s.mansoni implantados no dorso e 3 doses semanais de SMA. Os tumores destes animais foram reduzidos em 90 (por cento). A administração apenas de CY não interferiu com o crescimento do tumor. Os demais grupos tratados com SMA apenas ou associado à CY teiveram os tumores reduzidos em 40 (por cento) e 26 (por cento) respectivamente. Também foi analisada a produção de glicosaminoglicanas ao redor das células tumorais animais submetidos ou não ao tratamento com o antígeno. Surpreendentemente, o histiocitoma B10MC2 apresentou concentração muito reduzida de glicosaminoglicanas. Contudo, uma concentração significativa de sulfato de dermatana foi observada nos tumores dos animais tratados com vermes adultos e SMA. O tumor foi analisado por estudos histopatológicos, sendo observada uma deposição de fibras colágenas tipo I e III ao redor dos tumores dos animais de células mononucleares bem definido ao redor do tumor. A presença de eosinófilos foi observada tanto na área do infiltrado ao redor do tumor, quanto no estroma tumoral e tecidos sadios adjacentes. Também foi estudada a participação do sistema imune no processo de regressão, sendo verificado que as células esplênicas dos animais tratados, quando estimuladas com COnA, induziram uma proliferação de células CTLL 37 (por cento) maior que a dos animais controles normais. Já as células de baço dos animais sem tratamento suprimiram a proliferação das células CTLL.


Groups of B10A mice bearing fibrosarcoma B10MC2 were treated with agents which induces eosinophilia such as ciclophosphamide (CY) or Schistosoma mansoni antigens (SMA) or both, and the growth of their tumors was evaluated. Tumor growth was markedly attenuated in the growth of mice which had four pairs of S.mansoni adult worms implanted in the back 7 days before implantation of tumor cells and then received SMA three times a week. These animals had tumor growth reduced in 90%. CY alone, had no effect on tumor growth. Groups treated three times a week with SMA alone or associated with CY on day -2 had tumor growth reduced in 40% e 26% respectively. Production of glycosaminoglycans around tumor cells of animals submited or not to treatment with Schistosoma mansoni antigens (SMA) was analysed. The mouse histiocitoma B10MC2 was showed to have very low concetration of glycosaminoglycans.However, a significant amount of dermatan sulfate was found in tumor of treated animals. Tumor was also analysed by histopathological methods, and deposit of colagen fibers was seen around treated tumors. The inflamatory reaction observed around tumor was intense and predominantly mononuclear cells. Eosinophils was also seen among the inflamatory cells, in tumor stroma and in normal tissues around tumor. The participation of immune system in the process of tumor regression was also studied. Spleen cells from animals bearing tumor and treated with worm and SMA, when stimulated with ConA, were shown to induce the proliferation of CTLL cells 37% more than that of normal animal cells. The cells of non treated animals partially supressed the proliferation of CTLL cells.


Subject(s)
Animals , Eosinophils , Immunotherapy , Neoplasms , Schistosoma mansoni
SELECTION OF CITATIONS
SEARCH DETAIL